Jim Simons's position in Adma Biologics is currently worth $75.3 Million. That's 0.12% of their equity portfolio (204th largest holding). The investor owns 1.58% of the outstanding Adma Biologics stock. The first Adma Biologics trade was made in Q2 2017. Since then Jim Simons bought shares sixteen more times and sold shares on four occasions. The stake costed the investor $29.4 Million, netting the investor a gain of 156% so far.